Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

SOPH

+ Watchlist+ Portfolio

SOPHiA GENETICS SA

Recurring revenueRegulated industrySells to businessesTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$7.45
52-Week Range
$3.83 – $8.98
Market Cap
$639.87M
P/E (TTM)
—
EPS (TTM)
-1.09
Dividend Yield
0.00%
Advanced Metrics
Price/Book
9.35
PEG Ratio
—
Return on Equity
-125.67%
Return on Assets
-26.46%
Gross Margin
66.43%
Operating Margin
-81.02%
Profit Margin
-89.18%
Current Ratio
2.29
Debt/Equity
0.89
Total Debt
$61.04M
Free Cash Flow
$-25.56M
Revenue Growth
24.70%
Earnings Growth
—
Enterprise Value
$607.26M

Market Snapshot

About

SOPHiA GENETICS is a healthcare technology company that applies artificial intelligence and data analytics to genomic and multimodal data. The company operates a cloud-based platform that helps hospitals, laboratories, and biopharma institutions analyze complex genomic information for clinical diagnostics and drug development. SOPHiA GENETICS focuses on oncology, rare diseases, and other genetic conditions.